Primary Record
8-Hydroxyefavirenz
- In stock
- 6,945 g
- Purity
- 99.5 %
- CAS
- 205754-33-2
Compound Identifiers & Properties
- CAS
- 205754-33-2
- PubChem CID
- 487643
- SMILES
- C1CC1C#C[C@]2(C3=C(C(=CC(=C3)Cl)O)NC(=O)O2)C(F)(F)F
- Canonical SMILES
- O=C1Nc2c(O)cc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1
Names & Synonyms
- 8-Hydroxyefavirenz
- 8-hydroxy efavirenz
- 8-Hydroxy-efavirenz
- rac 8-Hydroxy Efavirenz
- 8-OH efavirenz
- 8-hydroxy EFV
- Efavirenz metabolite
- 205754-33-2
- P8S49CKH6L
- UNII-P8S49CKH6L
- AC1LAGG7
- RefChem:107169
- CHEMBL1309
- 8-Hydroxy Efavirenz (~90%)
- 8-OH EFV
- AC1Q4I0Z
- C14H9ClF3NO3
- 8-hydroxy-efavirenz-glucuronide
- orb1693108
- SCHEMBL29494828
- CTK4E4582
- DTXSID50942769
- OOVOMPCQLMFEDT-ZDUSSCGKSA-N
- AIDS110291
- KST-1A2589
- ZINC6524414
- AR-1A6099
- BDBM50097571
- CID487643
- MFCD09840726
- AKOS030255837
- FH27480
- (4S)-6-chloro-4-(2-cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
- DA-50018
- PD117321
- HY-137397
- CS-0138367
- NS00116200
- J1.525.087I
- G90704
- 2H-3,1-Benzoxazin-2-one,6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-
- A935414
- 205754-32-1
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-
- Q27286382
- (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- (4s)-6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one
- (S)-6-Chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
- 20677-77-4
- 2H-3,1-Benzoxazin-2-one,6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-
- 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- 6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one
- (4S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-4H-3,1-benzoxazine-2,8-diol
- 6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-4H-3,1-benzoxazine-2,8-diol
- (4S)-4alpha-(Trifluoromethyl)-4-(cyclopropylethynyl)-6-chloro-8-hydroxy-1,2-dihydro-4H-3,1-benzoxazine-2-one
- (4S)-6-chloro-4-(2-cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
- (4S)-8-Hydroxy-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzooxazine-2-one
- (S)-6-Chloro-4-cyclopropylethynyl-8-hydroxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-; 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)- (9CI); (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; 8-Hydroxyefavirenz; (4S)-6-chloro-4-(2-cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one